Can better surveillance of hepatitis b and d prevent liver damage?
NCT ID NCT07727187
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This observational study follows adults in France who are newly diagnosed with chronic hepatitis B (with or without hepatitis D). Researchers will measure liver scarring, treatment eligibility, and viral characteristics to understand how severe the disease is at diagnosis. The goal is to improve screening and care strategies to meet global targets for reducing hepatitis-related deaths.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This study could help improve screening and care for hepatitis B and D, potentially reducing liver-related deaths in France.
- What could go wrong
- As an observational study, it does not test a new treatment, so it will not directly change outcomes for participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stéphane Chevaliez
Créteil, 9400, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.